首页> 外文期刊>Acta Radiologica >Validation of diagnostic criteria using gadoxetic acid-enhanced and diffusion-weighted MR imaging for small hepatocellular carcinoma (<= 2.0 cm) in patients with hepatitis-induced liver cirrhosis.
【24h】

Validation of diagnostic criteria using gadoxetic acid-enhanced and diffusion-weighted MR imaging for small hepatocellular carcinoma (<= 2.0 cm) in patients with hepatitis-induced liver cirrhosis.

机译:使用牛磺酸增强和弥散加权MR成像对肝炎引起的肝硬化患者的小肝细胞癌(<= 2.0 cm)的诊断标准的验证。

获取原文
获取原文并翻译 | 示例
       

摘要

Gadoxetic acid and diffusion-weighted imaging (DWI) is increasingly used for the diagnosis of hepatocellular carcinoma (HCC). It is relevant to refine the diagnostic parameters for HCC, using state-of-the-art imaging techniques.To validate usefulness of magnetic resonance imaging (MRI) criteria with gadoxetic acid-enhanced MRI and DWI for diagnosis of small HCC by differentiation from dysplastic nodule (DN) or regenerative nodule (RN) in cirrhotic patients with strongly suspected small HCC.One hundred and eight patients with 102 HCCs and 29 benign nodules including 21 DNs and two large RNs (≤ 2.0 cm), and 40 patients with no HCC underwent gadoxetic acid-enhanced MRI and DWI. All patients also underwent MDCT. Index MR criteria for HCC were: (i) arterial hyperenhancement and hypointensity on hepatobiliary phase (HBP) with hyperintensity on DWI; (ii) hypovascular nodule with hyperintensity on DWI; (iii) arterial hyperenhancement and hypointensity on HBP without hyperintensity on DWI; (iv) arterial hyperenhancement and either iso- or hyperintensity on HBP, with hyperintensity on DWI; and (v) hyperintensity only on DWI. According to these criteria, MRI findings for HCCs and benign nodules were independently classified by two reviewers.On multidetector-row computed tomography, 64 HCCs (62.7%) showed typical features for HCC while 13 (12.8%) were not identified. On MRI, 84 HCCs (82.4%) showed arterial hyperenhancement and hypointensity on HBP, and hyperintensity on DWI. Eight HCCs were regarded as hypovascular HCCs with hyperintensity DWI (category 2). One HCC (0.6 cm in diameter) was demonstrated only by DWI. For each observer, 101 (99.0%) and 100 HCCs (98.0%) were discernible when applying all MRI criteria for HCC, respectively. Three DNs also fit the HCC criteria, thus the specificity was 90.9% for both observers.With the HCC criteria based on combined gadoxetic acid-enhanced MRI and DWI, it is possible to reliably diagnose small HCC including hypovascular HCCs.
机译:ado酸和弥散加权成像(DWI)越来越多地用于肝细胞癌(HCC)的诊断。使用最新的影像学技术来完善HCC的诊断参数是非常重要的。为了验证磁共振成像(MRI)标准与牛磺酸增强的MRI和DWI的区别,可以通过与发育异常的鉴别诊断小肝癌强烈怀疑有小肝癌的肝硬化患者中的小结节(DN)或再生结节(RN).108例有102例HCC和29例良性结节的患者,包括21例DN和2例大RN(≤2.0 cm),40例无HCC接受了鹿角酸增强的MRI和DWI。所有患者均接受了MDCT。肝癌的MR指标标准为:(i)肝胆期(HBP)的动脉过度增高和低强度,DWI时为高强度; (ii)DWI上的血管结节伴高强度; (iii)HBP的动脉过度增高和低血压,而DWI则无高血压; (iv)动脉过度增强,HBP呈等强度或高强度,DWI呈高强度; (v)仅在DWI上出现高强度。根据这些标准,两名检查者对HCC和良性结节的MRI结果进行了独立分类。在多排行计算机断层扫描中,有64例HCC(62.7%)显示出HCC的典型特征,而未发现13例(12.8%)。在MRI上,有84例HCC(占82.4%)在HBP上表现为动脉过度增强和低血压,在DWI上表现为高血压。 8例HCC被认为是DWI过多的血管下HCC(类别2)。仅DWI证实了一种HCC(直径0.6厘米)。当将所有MRI标准应用于HCC时,对于每个观察者,分别可识别101个(99.0%)和100个HCC(98.0%)。 3个DN也符合HCC标准,因此两位观察者的特异性均为90.9%。使用基于牛磺酸增强MRI和DWI的HCC标准,可以可靠地诊断包括血管充血性HCC在内的小型HCC。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号